Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US House adopts FDA user fee bill with ease; reconciliation with Senate ahead

This article was originally published in SRA

Executive Summary

The US House of Representatives on 30 May swiftly adopted its version of the Food and Drug Administration user fee bill in a somewhat anticlimactic 387-5 vote, without the fire-and-brimstoning that came in the Senate, although that chamber, too, easily passed its legislation, 96-1, with very little debate – a rare occurrence in Washington, especially lately1,2.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS116814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel